Jun 24, 2026 08:59PM
Apr 28, 2026 08:53PM
Apr 28, 2026 08:53PM
Apr 14, 2026 08:11PM
Apr 14, 2026 08:10PM
Apr 10, 2026 04:09PM
Apr 8, 2026 09:07AM Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
Apr 7, 2026 11:35PM
Mar 17, 2026 07:19PM
Mar 11, 2026 07:21PM
Feb 26, 2026 07:42PM
Feb 11, 2026 06:27PM
Jan 28, 2026 06:54PM
Jan 26, 2026 06:45PM Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
Jan 18, 2026 07:01PM
Jan 8, 2026 06:46PM
Jan 1, 2026 06:02PM
Jan 1, 2026 06:02PM
Dec 29, 2025 06:57PM
Dec 11, 2025 06:22PM
Dec 3, 2025 06:10PM Mesoblast Participation at Piper Sandler Conference
Nov 24, 2025 06:39PM
Nov 20, 2025 06:32PM
Nov 4, 2025 06:40PM
Oct 19, 2025 07:48PM
Oct 6, 2025 07:24PM
Oct 2, 2025 09:04PM
Sep 26, 2025 01:49AM Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
Sep 14, 2025 09:18PM
Sep 3, 2025 09:47PM
Aug 28, 2025 08:24PM
Jul 17, 2025 08:38PM
Jun 30, 2025 08:36PM
Jun 11, 2025 09:24PM
May 14, 2025 11:36PM Mesoblast Limited (MSB) received seven years of orphan-drug exclusive approval from US FDA
May 14, 2025 10:57PM
Apr 29, 2025 08:53PM
Apr 28, 2025 07:44PM
Apr 3, 2025 06:58PM
Apr 2, 2025 07:15PM
Mar 30, 2025 07:39PM
Mar 13, 2025 07:42PM Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States
Mar 6, 2025 06:54PM
Feb 26, 2025 05:30PM
Feb 25, 2025 06:13PM
Feb 23, 2025 06:33PM
Feb 13, 2025 06:37PM
Jan 30, 2025 07:11PM
Jan 30, 2025 06:20PM Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2024
Dec 18, 2024 07:08PM

324,417 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All